Format

Send to

Choose Destination
Front Pharmacol. 2013 Mar 26;4:32. doi: 10.3389/fphar.2013.00032. eCollection 2013.

Limbic system associated membrane protein as a potential target for neuropsychiatric disorders.

Author information

1
Department of Physiology, University of Tartu Tartu, Estonia.

Abstract

The studies performed in laboratory animals and psychiatric patients suggest a possible role of limbic system-associated membrane protein (LAMP) in the mechanisms of psychiatric disorders. Stressful manipulations and genetic invalidation have revealed a role of the Lsamp gene in the regulation of anxiety in rodents. Besides that, Lsamp-deficient mice display reduced aggressiveness and impaired adaptation in novel and stressful environments. The behavioral effects of amphetamine were blunted in genetically modified mice. Recent pharmacological and biochemical studies point toward altered function of GABA-, 5-hydroxytryptamine-, and dopaminergic systems in Lsamp-deficient mice. Moreover, we found an association between the gene polymorphisms of LSAMP and major depressive disorder (MDD). Patients suffering from MDD had significantly increased ratio between risk and protective haplotypes of the LSAMP gene compared to healthy volunteers. However, the impact of these haplotypes for the function of LAMP is not clear and remains to be elucidated in future studies.

KEYWORDS:

5-hydroxytryptamine; anxiety; dopamine; genetic polymorphisms; limbic system-associated membrane protein; major depressive disorder; panic disorder

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center